Linked Life Data

10453590

Source:http://linkedlifedata.com/resource/pubmed/id/10453590

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1999-9-8
pubmed:abstractText
This paper reports the clinical trial of Tang Shen Ning ([symbol: see text], TSN) for treating diabetic nephropathy (incipient and clinical, as divided by Mogensen). The results showed that the total effective rate in treatment group (TSN + western medicine) was 90.0%, and that in the control group (simply with western medicine), 56.7%. TSN plays important roles in decreasing proteinuria and improving renal functions.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0255-2922
pubmed:author
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
247-52
pubmed:dateRevised
2010-11-3
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
A clinical trial of tang shen ning for treatment of diabetic nephropathy.
pubmed:affiliation
Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine and Pharmacy.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial